Raffa Wealth Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.03K Sell
44
-2
-4% -$396 ﹤0.01% 454
2026
Q2
$8.62K Buy
+46
New +$6.72K ﹤0.01% 462

Other funds holding RVMD

Raffa Wealth Management's RVMD Position: Q3 2026 in Review

Raffa Wealth Management reduced its Revolution Medicines (RVMD) stake by 4.3% in Q3 2026, selling an estimated $396 and leaving 44 shares worth $9.03K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Raffa Wealth Management first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Raffa Wealth Management held 44 shares of Revolution Medicines worth $9.03K as of Q3 2026.
  • Raffa Wealth Management sold 2 Revolution Medicines shares in Q3 2026, an estimated $396.
  • Revolution Medicines made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #454 holding.
  • Raffa Wealth Management first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.